tiprankstipranks
Pressure Biosciences (PBIO)
OTHER OTC:PBIO
US Market

Pressure Biosciences (PBIO) Financial Statements

58 Followers

Pressure Biosciences Financial Overview

Pressure Biosciences's market cap is currently ―. The company's EPS TTM is $-1.617; its P/E ratio is -0.07; Pressure Biosciences is scheduled to report earnings on August 15, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 413.01K$ 512.00K$ 741.00K$ 607.00K$ 144.03K
Gross Profit$ 183.55K$ 255.40K$ 1.10M$ -664.30K$ 17.83K
EBIT$ -1.29M$ -1.04M$ 5.13M$ -1.53M$ -2.43M
EBITDA$ -1.26M$ 195.50K$ 5.78M$ -1.47M$ -2.42M
Net Income Common Stockholders$ -6.26M$ -11.11M$ 1.47M$ -4.89M$ -4.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.26K$ 24.98K$ 239.02K$ 3.87K$ 230.88K
Total Assets$ 1.60M$ 1.68M$ 2.21M$ 2.01M$ 2.84M
Total Debt$ 20.55M$ 18.78M$ 19.25M$ 19.89M$ 19.29M
Net Debt$ 20.55M$ 18.76M$ 19.01M$ 19.89M$ 19.06M
Total Liabilities$ 30.20M$ 26.79M$ 34.66M$ 34.70M$ 32.62M
Stockholders Equity$ -28.60M$ -25.12M$ -32.45M$ -32.69M$ -29.78M
Cash Flow-
Free Cash Flow$ -736.93K$ -899.17K$ -425.21K$ -1.43M$ -1.07M
Operating Cash Flow$ -732.44K$ -899.17K$ -422.21K$ -1.43M$ -1.05M
Investing Cash Flow$ -4.50K-$ -3.00K$ -1.00$ -15.86K
Financing Cash Flow$ 717.22K$ 685.13K$ 660.37K$ 1.20M$ 1.18M
Currency in USD

Pressure Biosciences Earnings and Revenue History

Pressure Biosciences Debt to Assets

Pressure Biosciences Cash Flow

Pressure Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis